[go: up one dir, main page]

AU9279601A - Compounds and methods for use thereof in the treatment of cancer or viral infections - Google Patents

Compounds and methods for use thereof in the treatment of cancer or viral infections

Info

Publication number
AU9279601A
AU9279601A AU9279601A AU9279601A AU9279601A AU 9279601 A AU9279601 A AU 9279601A AU 9279601 A AU9279601 A AU 9279601A AU 9279601 A AU9279601 A AU 9279601A AU 9279601 A AU9279601 A AU 9279601A
Authority
AU
Australia
Prior art keywords
cancer
compounds
treatment
methods
viral infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU9279601A
Inventor
James C Quada Jr
Joseph K Agyin
James Berger Camden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/670,166 external-priority patent/US6608096B1/en
Priority claimed from US09/670,170 external-priority patent/US6380232B1/en
Priority claimed from US09/670,168 external-priority patent/US6462062B1/en
Priority claimed from US09/670,169 external-priority patent/US6407105B1/en
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU9279601A publication Critical patent/AU9279601A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU9279601A 2000-09-26 2001-09-19 Compounds and methods for use thereof in the treatment of cancer or viral infections Pending AU9279601A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/670,166 US6608096B1 (en) 2000-09-26 2000-09-26 Compounds and methods for use thereof in the treatment of cancer or viral infections
US09/670,170 US6380232B1 (en) 2000-09-26 2000-09-26 Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US09/670,168 US6462062B1 (en) 2000-09-26 2000-09-26 Compounds and methods for use thereof in the treatment of cancer or viral infections
US09/670,169 US6407105B1 (en) 2000-09-26 2000-09-26 Compounds and methods for use thereof in the treatment of cancer or viral infections
PCT/US2001/029261 WO2002026716A2 (en) 2000-09-26 2001-09-19 Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections

Publications (1)

Publication Number Publication Date
AU9279601A true AU9279601A (en) 2002-04-08

Family

ID=27505337

Family Applications (2)

Application Number Title Priority Date Filing Date
AU9279601A Pending AU9279601A (en) 2000-09-26 2001-09-19 Compounds and methods for use thereof in the treatment of cancer or viral infections
AU2001292796A Ceased AU2001292796B2 (en) 2000-09-26 2001-09-19 Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001292796A Ceased AU2001292796B2 (en) 2000-09-26 2001-09-19 Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections

Country Status (6)

Country Link
EP (1) EP1330441A2 (en)
JP (1) JP2004509949A (en)
AU (2) AU9279601A (en)
CA (1) CA2422916A1 (en)
MX (1) MXPA03002601A (en)
WO (1) WO2002026716A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
KR100765841B1 (en) 2000-09-11 2007-10-10 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 Quinolinone derivatives as tyrosine kinase inhibitors
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US20030144312A1 (en) * 2001-10-30 2003-07-31 Schoenhard Grant L. Inhibitors of ABC drug transporters in multidrug resistant cancer cells
WO2003082273A1 (en) 2002-03-26 2003-10-09 Arizona Board Of Regents On Behalf Of The University Of Arizona Solubilization of weak bases
US7205412B2 (en) * 2002-07-03 2007-04-17 Samsung Electronics Co., Ltd. Antibiotic additive and ink composition comprising the same
BR0313743A (en) 2002-08-23 2005-07-05 Chiron Corp Benzimidazole quinolinones and uses of these
JP2004115397A (en) * 2002-09-25 2004-04-15 Fuji Photo Film Co Ltd Liposome comprising therapeutic agent for vascular disease
WO2005094897A2 (en) * 2004-04-01 2005-10-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds
CA2608087C (en) 2005-05-17 2013-12-10 Gabriel Calvin Methods for synthesizing heterocyclic compounds
CN102333568B (en) * 2008-12-24 2016-01-20 比亚尔-珀特拉和Ca股份公司 Pharmaceutical compounds
KR101064258B1 (en) 2008-12-29 2011-09-14 한국과학기술연구원 Benzoarylureido compound, and composition for preventing or treating degenerative brain disease containing the same
CN103450093A (en) * 2013-09-06 2013-12-18 中国药科大学 2-aminobenzimidazoles and applications thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3399212A (en) * 1966-05-16 1968-08-27 Smith Kline French Lab Benzimidazole ureas
US3480642A (en) * 1967-03-22 1969-11-25 Smithkline Corp Process for producing 2-carbalkoxyaminobenzimidazoles
DE2253324A1 (en) * 1972-10-31 1974-05-09 Bayer Ag 1-ALKOXYCARBONYL-2-SQUARE BRACKETS ON UP- (ALKOXYCARBONYL) -AMINO SQUARE BRACKETS FOR -BENZIMIDAZOLE, THE PROCESS FOR THEIR PRODUCTION AND THEIR USE AS FUNGICIDES
HU177582B (en) * 1977-10-25 1981-11-28 Chinoin Gyogyszer Es Vegyeszet Fungicide preparations containing new benzimidazole derivatives and process for preparing the active materials thereof
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
PE11499A1 (en) * 1997-05-16 1999-03-01 Procter & Gamble TREATMENT OF HIV AND CANCER

Also Published As

Publication number Publication date
WO2002026716A3 (en) 2002-07-11
AU2001292796B2 (en) 2005-12-22
WO2002026716A2 (en) 2002-04-04
EP1330441A2 (en) 2003-07-30
MXPA03002601A (en) 2005-02-25
JP2004509949A (en) 2004-04-02
CA2422916A1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU6147401A (en) Compositions and methods for the treatment of cancer
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
EP1355563A4 (en) METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
IL129352A0 (en) Benzimidazole-2- carbamates for the treatment of viral infections and cancer
GB0109537D0 (en) Well treatment fluids and methods for the use thereof
EE05507B1 (en) Use of rosuvastatin ZD4522) in the treatment of heterosgococcal family h percolesterolemia
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
AU2002346644A1 (en) Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
MXPA03008582A (en) Agents and methods for treatment of cancer.
SI1197485T1 (en) Cyclobuten-dione derivatives for use in the treatment of artherosclerosis
PL368035A1 (en) Compositions and methods for the treatment of cancer
HK1050011A1 (en) Treatment of viral infections using levovirintm
AU6814601A (en) Use of mutant herpes viruses and anticancer agents in the treatment of cancer
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
IL160722A0 (en) Aryloxypropylamines as chemosensitizing agents in the treatment of cancer
EE200300057A (en) Ingredients for the prevention and treatment of cancer
AP2002002432A0 (en) Treatment of viral infections
PL349910A1 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
AU5565401A (en) Materials and methods for the treatment of depression
GB0007217D0 (en) Materials and methods relating to the treatment of leukaemias
EP1322319A4 (en) Use of il-8 protein modulators in the treatment of viral infections
AU2002366195A8 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer